#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Synovitis Immune-mediated renal disorder Haematological malignancy Chronic inflammatory demyelinating polyradiculoneuropathy Peripheral primitive neuroectodermal tumour of soft tissue Heavy menstrual bleeding Kidney transplant rejection Cystic fibrosis lung Polycythaemia vera Hypertriglyceridaemia Philadelphia positive chronic myeloid leukaemia Muscular dystrophy Ewing's sarcoma Stress cardiomyopathy B-cell small lymphocytic lymphoma More trials…

    Learn about Rare Diseases

    Hereditary ataxia – Diagnostics Fragile X syndrome – Life with Disease Leiomyosarcoma Vascular malformation Synovial sarcoma metastatic – Basic Information Bronchiolitis obliterans syndrome – Trials in Disease Focal segmental glomerulosclerosis Pleural mesothelioma malignant – Basic Information Atypical haemolytic uraemic syndrome – Diagnostics Haemolytic uraemic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iptacopan THEOPHYLLINE ANHYDROUS Oxymetazoline Hydrochloride Antipsychotics Modafinil Cx-044933 Insulin Glargine Metoprolol Succinate Imifoplatin Timothy Grass Pollen Extract Recombinant Interferon Beta-1B Purified Egg Phospholipids Linezolid Mps-214 Hu5F9‐G4 Oleclumab Tiemonium Methylsulphate Alanine Oxacillin Bi 1291583 More therapies…

    Learn about Your Condition

    Persistent depressive disorder Neurotrophic keratopathy Stem cell transplant Small intestine carcinoma Hereditary ataxia Small cell lung cancer Nocturia Diffuse large B-cell lymphoma Hepatic neoplasm Wolfram syndrome Primary biliary cholangitis Renal disorder Acute HIV infection Choroidal neovascularisation Plasma cell myeloma refractory More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin ulcer

  • Study on the Effectiveness of EscharEx and Amnion/Chorion Membrane Allograft for Patients with Venous Leg Ulcers

    Recruiting

    3 1
    Austria Germany Italy Poland Spain

  • Study on Acetic Acid for Healing Skin Ulcers in Patients with Biofilm

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Skin ulcer
    Investigated Drugs:
    • Acetic Acid, Glacial
    Spain

  • Safety and Efficacy of EscharEx (concentrate of proteolytic enzymes enriched in bromelain) in Adults with Venous Leg Ulcers

    Not yet recruiting

    2 1
    Czechia Slovakia

  • Study on Stem Cell Treatment for Venous Ulcers in the Legs Using Bioengineered Artificial Mesenchymal Sheet (BAMS)

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Skin ulcer
    Investigated Drugs:
    • Allogenic Adipose-Derived Adult Mesenchymal Stem Cells Expanded On Fibrin-Hyaluronic Biological Matrix
    Spain

  • Study on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers

    Not recruiting

    3 1
    Investigated Drugs:
    • Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
    Austria Czechia France Germany Hungary Italy +4

  • Study on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds

    Not recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!